{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:29:42Z","timestamp":1793651382370,"version":"4.5.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Ex vivo lung perfusion (EVLP) has expanded the use of donor lungs by enabling ex vivo assessment, preservation, and rehabilitation before transplantation. Despite these advances, ischemia-reperfusion injury, inflammatory activation, pulmonary edema, and impaired lung mechanics continue to compromise graft quality and contribute to primary graft dysfunction. Inhaled and gaseous interventions have emerged as potential adjunctive therapies to improve donor lung preservation during EVLP; however, a standardized protocol has not yet been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>PubMed and Embase were used to search human and animal studies evaluating inhaled and gaseous interventions administered during and after EVLP. Articles published from the database\u2019s inception to September 22, 2025, were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Among the interventions examined, 10% carbon dioxide, carbon monoxide (CO), 40% oxygen (O\n                      <jats:sub>2<\/jats:sub>\n                      ), hydrogen, 40\u2009ppm nitric oxide (NO) with 60% O\n                      <jats:sub>2<\/jats:sub>\n                      , 2% sevoflurane with 40%\u201350% O\n                      <jats:sub>2<\/jats:sub>\n                      , 2-S-amino-6-boronohexanoic acid, fasudil, and \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      -adrenoreceptor agonists most effectively improved lung function. Interestingly, improvements from hydrogen and CO were observed after transplantation, rather than during EVLP, suggesting more persistent or delayed protective effects. Further optimized parameters were observed when moderate O\n                      <jats:sub>2<\/jats:sub>\n                      concentrations (40%\u201360%) were combined with either CO, NO, or sevoflurane, compared with O\n                      <jats:sub>2<\/jats:sub>\n                      alone. In contrast, argon, xenon, N-acetylcysteine, sevoflurane or NO with 6% O\n                      <jats:sub>2<\/jats:sub>\n                      , and liquid ventilation demonstrated minimal benefit.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>\n                      Inhaled interventions can attenuate both mechanical damage and inflammatory pathways, particularly when used in tailored combinations with 40%\u201360% O\n                      <jats:sub>2<\/jats:sub>\n                      . Future research should prioritize standardizing protocols, optimizing gas composition and timing, and assessing long-term posttransplant outcomes to translate these findings into clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000002012","type":"journal-article","created":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:00:28Z","timestamp":1793649628000},"page":"e2012","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparing Gas and Inhaled Pharmacologic Interventions During Ex Vivo Lung Perfusion: A Systematic Review"],"prefix":"10.1097","volume":"12","author":[{"given":"Maira","family":"Machhiwala","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7146-4337","authenticated-orcid":false,"given":"Ryaan","family":"EL-Andari","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Hassanzadeh","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren H.","family":"Freed","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayan","family":"Nagendran","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"R1-20261102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.semtcvs.2008.04.006","article-title":"Current strategies in donor selection and management.","volume":"20","author":"Botha","year":"2008","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R2-20261102","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.21037\/jtd-2021-18","article-title":"Primary graft dysfunction: what we know.","volume":"13","author":"Clausen","year":"2021","journal-title":"J Thorac Dis"},{"key":"R3-20261102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0033-1348474","article-title":"Primary graft dysfunction.","volume":"34","author":"Suzuki","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"R4-20261102","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1164\/rccm.200401-023OC","article-title":"Inhaled carbon monoxide confers antiinflammatory effects against ventilator-induced lung injury.","volume":"170","author":"Dolinay","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20261102","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.3390\/molecules28237785","article-title":"Molecular hydrogen therapy\u2014a review on clinical studies and outcomes.","volume":"28","author":"Johnsen","year":"2023","journal-title":"Molecules"},{"key":"R6-20261102","doi-asserted-by":"crossref","first-page":"1598798","DOI":"10.3389\/fmed.2025.1598798","article-title":"Medical gases in respiratory diseases: ozone, argon, and nitric oxide as game-changers in therapeutics.","volume":"12","author":"Chen","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R7-20261102","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.3390\/jcm13154440","article-title":"Ex vivo lung perfusion and primary graft dysfunction following lung transplantation: a contemporary united network for organ sharing database analysis.","volume":"13","author":"Gouchoe","year":"2024","journal-title":"J Clin Med"},{"key":"R8-20261102","doi-asserted-by":"crossref","first-page":"S728","DOI":"10.1016\/j.healun.2025.02.1566","article-title":"Optimized cellular perfusate increases lung viability ex vivo and extends the duration of ex vivo lung perfusion.","volume":"44","author":"Arnold","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"R9-20261102","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R10-20261102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies.","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R11-20261102","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.healun.2016.10.014","article-title":"Optimal ex vivo lung perfusion techniques with oxygenated perfusate.","volume":"36","author":"Noda","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R12-20261102","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1089\/ten.tea.2022.0084","article-title":"Liquid ventilation reconditions isolated rat lungs following ischemia-reperfusion injury.","volume":"28","author":"Becerra","year":"2022","journal-title":"Tissue Eng Part A"},{"key":"R13-20261102","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1111\/j.1600-6143.2009.02840.x","article-title":"Nitric oxide ventilation of rat lungs from non-heart-beating donors improves posttransplant function.","volume":"9","author":"Dong","year":"2009","journal-title":"Am J Transplant"},{"key":"R14-20261102","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jtcvs.2012.11.005","article-title":"Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors.","volume":"146","author":"Dong","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R15-20261102","doi-asserted-by":"crossref","first-page":"1440.e1","DOI":"10.1016\/j.jtcvs.2005.06.037","article-title":"Hyperoxic ventilation exacerbates lung reperfusion injury.","volume":"130","author":"Ellman","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R16-20261102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jss.2012.11.012","article-title":"A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform.","volume":"183","author":"George","year":"2013","journal-title":"J Surg Res"},{"key":"R17-20261102","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ejcts\/ezv057","article-title":"The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death.","volume":"48","author":"Haam","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"R18-20261102","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.healun.2018.06.007","article-title":"Hydrogen gas inhalation during ex vivo lung perfusion of donor lungs recovered after cardiac death.","volume":"37","author":"Haam","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R19-20261102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s41030-022-00209-5","article-title":"A randomized, multicenter, blinded pilot study assessing the effects of gaseous nitric oxide in an ex vivo system of human lungs.","volume":"9","author":"Hartwig","year":"2023","journal-title":"Pulm Ther"},{"key":"R20-20261102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1139\/cjpp-2024-0135","article-title":"Inhaled argon dilates pulmonary vasculature in rat isolated lungs.","volume":"103","author":"Hees","year":"2025","journal-title":"Can J Physiol Pharmacol"},{"key":"R21-20261102","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.athoracsur.2016.07.066","article-title":"Bronchodilator inhalation during ex vivo lung perfusion improves posttransplant graft function after warm ischemia.","volume":"103","author":"Hijiya","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"R22-20261102","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.healun.2024.09.019","article-title":"The combination of postmortem sevoflurane ventilation and in situ topical cooling provides improved 6 hours lung preservation in an uncontrolled DCD porcine model.","volume":"44","author":"Junior","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"R23-20261102","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jss.2024.05.048","article-title":"Therapeutic use of carbon monoxide in Ex-Vivo lung perfusion in donor with prolonged cold ischemia.","volume":"301","author":"Kalaf-Mussi","year":"2024","journal-title":"J Surg Res"},{"key":"R24-20261102","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.athoracsur.2015.02.136","article-title":"\u03b22-Adrenoreceptor agonist inhalation during ex vivo lung perfusion attenuates lung injury.","volume":"100","author":"Kondo","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"R25-20261102","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/00003246-200005000-00044","article-title":"Effects of partial liquid ventilation on regional pulmonary blood flow distribution of isolated rabbit lungs.","volume":"28","author":"Loer","year":"2000","journal-title":"Crit Car Med"},{"key":"R26-20261102","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jss.2015.10.007","article-title":"Argon and xenon ventilation during prolonged ex vivo lung perfusion.","volume":"201","author":"Martens","year":"2016","journal-title":"J Surg Res"},{"key":"R27-20261102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/2045-9912.202907","article-title":"A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury.","volume":"7","author":"Martens","year":"2017","journal-title":"Med Gas Res"},{"key":"R28-20261102","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jtcvs.2020.11.150","article-title":"Safety of continuous 12-hour delivery of antimicrobial doses of inhaled nitric oxide during ex vivo lung perfusion.","volume":"163","author":"Michaelsen","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R29-20261102","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/TP.0000000000000254","article-title":"Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats.","volume":"98","author":"Noda","year":"2014","journal-title":"Transplantation"},{"key":"R30-20261102","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.athoracsur.2016.07.067","article-title":"Protective effect of inhaled rho-kinase inhibitor on lung ischemia-reperfusion injury.","volume":"103","author":"Ohata","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"R31-20261102","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/ijms25042413","article-title":"Ex vivo optimization of donor lungs with inhaled sevoflurane during normothermic ex vivo lung perfusion (VITALISE): a pilot and feasibility study in sheep.","volume":"25","author":"Steink\u00fchler","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R32-20261102","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/icvts\/ivx438","article-title":"Experimental ex vivo lung perfusion with sevoflurane: effects on damaged donor lung grafts.","volume":"26","author":"Wang","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R33-20261102","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/CCM.0b013e318232d776","article-title":"Hypercapnic acidosis attenuates reperfusion injury in isolated and perfused rat lungs.","volume":"40","author":"Wu","year":"2012","journal-title":"Crit Care Med"},{"key":"R34-20261102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jss.2017.06.061","article-title":"Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation.","volume":"218","author":"Yamada","year":"2017","journal-title":"J Surg Res"},{"key":"R35-20261102","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1152\/jappl.2001.91.3.1121","article-title":"Role of airway nitric oxide on the regulation of pulmonary circulation by carbon dioxide.","volume":"91","author":"Yamamoto","year":"2001","journal-title":"J Appl Physiol (1985)"},{"key":"R36-20261102","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00408-010-9234-7","article-title":"Effect of carbon dioxide on pulmonary vascular tone at various pulmonary arterial pressure levels induced by endothelin-1.","volume":"188","author":"Chuang","year":"2010","journal-title":"Lung"},{"key":"R37-20261102","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.2174\/1568026621666211116090917","article-title":"Carbon monoxide as a therapeutic for airway diseases: contrast and comparison of various CO delivery modalities.","volume":"21","author":"Tripathi","year":"2021","journal-title":"Curr Top Med Chem"},{"key":"R38-20261102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/medsci6020033","article-title":"Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives.","volume":"6","author":"Khan","year":"2018","journal-title":"Med Sci (Basel)"},{"key":"R39-20261102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1631\/jzus.B2100420","article-title":"Molecular hydrogen is a promising therapeutic agent for pulmonary disease.","volume":"23","author":"Fu","year":"2022","journal-title":"J Zhejiang Univ Sci B"},{"key":"R40-20261102","first-page":"1377","article-title":"Interleukin-10 deficiency impacts on TNF-induced NF\u03baB regulated responses in vivo.","volume":"11","author":"Papoutsopoulou","year":"2022","journal-title":"Biology (Basel)"},{"key":"R41-20261102","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2024.03.022","article-title":"Hydrogen alleviates impaired lung epithelial barrier in acute respiratory distress syndrome via inhibiting Drp1-mediated mitochondrial fission through the Trx1 pathway.","volume":"218","author":"Long","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"R42-20261102","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1208\/s12248-017-0136-y","article-title":"siRNA-mediated RNA interference in precision-cut tissue slices prepared from mouse lung and kidney.","volume":"19","author":"Ruigrok","year":"2017","journal-title":"AAPS J"},{"key":"R43-20261102","doi-asserted-by":"crossref","first-page":"L1099","DOI":"10.1152\/ajplung.00217.2007","article-title":"Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice.","volume":"293","author":"Bland","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R44-20261102","doi-asserted-by":"crossref","first-page":"16239","DOI":"10.1038\/s41598-019-52813-2","article-title":"The effects of oxygen concentration on cell death, anti-oxidant transcription, acute inflammation, and cell proliferation in precision-cut lung slices.","volume":"9","author":"Ruigrok","year":"2019","journal-title":"Sci Rep"},{"key":"R45-20261102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s43166-024-00275-4","article-title":"Serum malondialdehyde as a marker of oxidative stress in rheumatoid arthritis.","volume":"51","author":"Nabih","year":"2024","journal-title":"Egypt Rheumatol Rehabil"},{"key":"R46-20261102","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1203\/00006450-200010000-00021","article-title":"Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets.","volume":"48","author":"Villamor","year":"2000","journal-title":"Pediatr Res"},{"key":"R47-20261102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","article-title":"Protein carbonyl groups as biomarkers of oxidative stress.","volume":"329","author":"Dalle-Donne","year":"2003","journal-title":"Clin Chim Acta"},{"key":"R48-20261102","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1165\/rcmb.2013-0453TR","article-title":"Anatomy and bronchoscopy of the porcine lung: a model for translational respiratory medicine.","volume":"51","author":"Judge","year":"2014","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000002012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:00:34Z","timestamp":1793649634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000002012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000002012","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"2026-02-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}